drugset / Trial / NCT02342925
A Study of the Effect of RG1662 on Metformin in Healthy Volunteers
Non-randomizedCrossoverOpen-label
Summary
This single-center, non-randomized, open-label, two treatment, two period, fixed sequence crossover study will investigate the effect of RG1662 treatment on the activity of key renal transporters in healthy male and female participants using metformin. The effect of RG1662 on other renal function parameters will also be explored.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Basmisanil | Small molecule | — | Oral |
| Subject | Metformin | Small molecule | 850 mg | — |
Indications
No indication recorded.